Postprandial Changes in High Density Lipoproteins in Rats Subjected to Gavage Administration of Virgin Olive Oil

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Martínez Beamonte, Roberto ^a,d   Navarro, María A ^a,d   Acin, Sergio ^a,d   Guillén, Natalia ^a,d   Barranquero, Cristina ^a,d   Arnal, Carmen ^b,d   Surra, Joaquín ^c,d   Osada, Jesus ^a,d  

^a INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN IIS ARAGÓN   (Spain)

^b UNIVERSIDAD DE ZARAGOZA   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE 1; CP 346086; HIGH DENSITY LIPOPROTEIN; MESSENGER RNA; OLIVE OIL; PHOSPHOLIPID TRANSFER PROTEIN; PROTEIN INHIBITOR; SPHINGOMYELIN; TRIACYLGLYCEROL; TYLOXAPOL; UNCLASSIFIED DRUG;

ABCA1 GENE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOLIPOPROTEIN A1 GENE; APOLIPOPROTEIN A1BP GENE; APOLIPOPROTEIN A2 GENE; APOLIPOPROTEIN A4 GENE; APOLIPOPROTEIN E GENE; ARTICLE; CONTROLLED STUDY; DUODENUM; FAT INTAKE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCATION; ILEUM; JEJUNUM; LCAT GENE; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIVER; MALE; NONHUMAN; PHOSPHOLIPID TRANSFER PROTEIN GENE; PLA2G7 GENE; PON1 GENE; POSTPRANDIAL STATE; RAT; SCARB1 GENE; SPHINGOMYELIN 1 GENE;

ADMINISTRATION, ORAL; ANIMALS; GENE EXPRESSION PROFILING; INTESTINE, SMALL; ISOQUINOLINES; LIPIDS; LIPOPROTEINS, HDL; LIVER; PLANT OILS; POLYETHYLENE GLYCOLS; POSTPRANDIAL PERIOD; RATS; RNA, MESSENGER; SPHINGOMYELINS; TRIAZOLES; TRIGLYCERIDES;

EID: 84873840146     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055231     Document Type: Article

References (67)

1. Redgrave TG, (2008) Chylomicrons in disease-future challenges Invited keynote address. Atheroscler Suppl 9: 3-6.
2. Kannel WB, Vasan RS, (2009) Triglycerides as vascular risk factors: new epidemiologic insights. Curr Opin Cardiol 24: 345-350.
3. Iqbal J, Hussain MM, (2009) Intestinal lipid absorption. Am J Physiol Endocrinol Metab 296: E1183-E1194.
4. Hussain MM, Kedees MH, Singh K, Athar H, Jamali NZ, (2001) Signposts in the assembly of chylomicrons. Front Biosci 6: D320-D331.
5. Mahley RW, Huang Y, Rall SC Jr, (1999) Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res 40: 1933-1949.
6. Cianflone K, Paglialunga S, Roy C, (2008) Intestinally derived lipids: metabolic regulation and consequences-an overview. Atheroscler Suppl 9: 63-68.
7. Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F, Ordovas JM, (2008) Influence of genetic factors in the modulation of postprandial lipemia. Atheroscler Suppl 9: 49-55.
8. Bergeron N, Havel RJ, (1997) Assessment of postprandial lipemia: nutritional influences. Curr Opin Lipidol 8: 43-52.
9. Lairon D, (2008) Macronutrient intake and modulation on chylomicron production and clearance. Atheroscler Suppl 9: 45-48.
10. Xu T, Li X, Ma X, Zhang Z, Zhang T, et al. (2009) Effect of diacylglycerol on postprandial serum triacylglycerol concentration: a meta-analysis. Lipids 44: 161-168.
11. Weinstock PH, Bisgaier CL, Aalto-Setala K, Radner H, Ramakrishnan R, et al. (1995) Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J Clin Invest 96: 2555-2568.
12. Young SG, Cham CM, Pitas RE, Burri BJ, Connolly A, et al. (1995) A genetic model for absent chylomicron formation: Mice producing apolipoprotein B in the liver, but not in the intestine. J Clin Invest 96: 2932-2946.
13. Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, et al. (1994) Targeted disruption of the apolipoprotein C-III gene in mice results in hypertriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem 269: 23610-23616.
14. Lou-Bonafonte JM, Fito M, Covas MI, Farras M, Osada J, (2012) HDL-Related Mechanisms of Olive Oil Protection in Cardiovascular Disease. Curr Vasc Pharmacol 10: 392-409.
15. Overturf ML, Loose-Mitchell DS, (1992) In vivo model systems: the choice of the experimental animal model for analysis of lipoproteins and atherosclerosis. Curr Opin Lipidol 3: 179-185.
16. Tall AR, Sammet D, Granot E, (1986) Mechanisms of enhance cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J Clin Invest 77: 1163-1172.
17. Hewing B, Fisher EA, (2012) Rationale for cholesteryl ester transfer protein inhibition. Curr Opin Lipidol.
18. Barter P, Rye KA, (2011) Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: Where are we now? Trends Pharmacol Sci 32: 694-699.
19. Clark RW, Sutfin TA, Ruggeri RB, Willauer AT, Sugarman ED, et al. (2004) Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib. Arterioscler Thromb Vasc Biol 24: 490-497.
20. Calleja L, Trallero MC, Carrizosa C, Mendez MT, Palacios-Alaiz E, et al. (2000) Effects of dietary fat amount and saturation on the regulation of hepatic mRNA and plasma apolipoprotein A-I in rats. Atherosclerosis 152: 69-78.
21. Osada J, Fernandez-Sanchez A, Diaz-Morillo JL, Miró-Obradors MJ, Cebrián JA, et al. (1994) Differential effect of dietary fat saturation and cholesterol on hepatic apolipoprotein gene expression in rats. Atherosclerosis 108: 83-90.
22. Martinez-Beamonte R, Navarro MA, Guillen N, Acin S, Arnal C, et al. (2011) Postprandial transcriptome associated with virgin olive oil intake in rat liver. Front Biosci (Elite Ed) 3: 11-21.
23. Martinez-Beamonte R, Navarro MA, Larraga A, Strunk M, Barranquero C, et al. (2011) Selection of reference genes for gene expression studies in rats. J Biotechnol 151: 325-334.
24. Chandler CE, Wilder DE, Pettini JL, Savoy YE, Petras SF, et al. (2003) CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. J Lipid Res 44: 1887-1901.
25. Borensztajn J, Rone MS, Kotlar TJ, (1976) The inhibition in vivo of lipoprotein lipase (clearing-factor lipase) activity by triton WR-1339. Biochem J 156: 539-543.
26. Kalogeris TJ, Fukagawa K, Tso P, (1994) Synthesis and lymphatic transport of intestinal apolipoprotein A-IV in response to graded doses of triglyceride. J Lipid Res 35: 1141-1151.
27. Kalogeris TJ, Rodriguez MD, Tso P, (1997) Control of synthesis and secretion of intestinal apolipoprotein A-IV by lipid. J Nutr 127: S537-S543.
28. Kusunoki J, Aragane K, Kitamine T, Kozono H, Kano K, et al. (2000) Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A:cholesterol acyltransferase activity. Arterioscler Thromb Vasc Biol 20: 171-178.
29. Cozzi J, Anegon I, Braun V, Gross AC, Merrouche C, et al. (2009) Pronuclear DNA injection for the production of transgenic rats. Methods Mol Biol 561: 73-88.
30. Geurts AM, Cost GJ, Freyvert Y, Zeitler B, Miller JC, et al. (2009) Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325: 433.
31. Reymer PW, Gagne E, Groenemeyer BE, Zhang H, Forsyth I, et al. (1995) A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet 10: 28-34.
32. Kalogeris TJ, Tsuchiya T, Fukagawa K, Wolf R, Tso P, (1996) Apolipoprotein A-IV synthesis in proximal jejunum is stimulated by ileal lipid infusion. Am J Physiol 270: G277-286.
33. Rodriguez MD, Kalogeris TJ, Wang XL, Wolf R, Tso P, (1997) Rapid synthesis and secretion of intestinal apolipoprotein A-IV after gastric fat loading in rats. Am J Physiol 272: R1170-1177.
34. Elshourbagy NA, Boguski MS, Liao WS, Jefferson LS, Gordon JI, et al. (1985) Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin. Proc Natl Acad Sci U S A 82: 8242-8246.
35. Sonoyama K, Tajima K, Fujiwara R, Kasai T, (2000) Intravenous infusion of hexamethonium and atropine but not propranolol diminishes apolipoprotein A-IV gene expression in rat ileum. J Nutr 130: 637-641.
36. Rubin DC, (1992) Spatial analysis of transcriptional activation in fetal rat jejunal and ileal gut epithelium. Am J Physiol 263: G853-863.
37. Apfelbaum TF, Davidson NO, Glickman RM, (1987) Apolipoprotein A-IV synthesis in rat intestine: regulation by dietary triglyceride. Am J Physiol 252: G662-666.
38. Tso P, Liu M, Kalogeris TJ, Thomson AB, (2001) The role of apolipoprotein A-IV in the regulation of food intake. Annu Rev Nutr 21: 231-254.
39. Glatzle J, Darcel N, Rechs AJ, Kalogeris TJ, Tso P, et al. (2004) Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway. Am J Physiol Regul Integr Comp Physiol 287: R354-359.
40. Spaulding HL, Saijo F, Turnage RH, Alexander JS, Aw TY, et al. (2006) Apolipoprotein A-IV attenuates oxidant-induced apoptosis in mitotic competent, undifferentiated cells by modulating intracellular glutathione redox balance. Am J Physiol Cell Physiol 290: C95-C103.
41. Vowinkel T, Mori M, Krieglstein CF, Russell J, Saijo F, et al. (2004) Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest 114: 260-269.
42. Duverger N, Ghalim N, Theret N, Fruchart JC, Castro G, (1994) Lipoproteins containing apolipoprotein A-IV: composition and relation to cholesterol esterification. Biochim Biophys Acta 1211: 23-28.
43. Guillen N, Navarro MA, Surra JC, Arnal C, Fernandez-Juan M, et al. (2007) Cloning, characterization, expression and comparative analysis of pig Golgi membrane sphingomyelin synthase 1. Gene 388: 117-124.
44. Liu J, Zhang H, Li Z, Hailemariam TK, Chakraborty M, et al. (2009) Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice. Arterioscler Thromb Vasc Biol 29: 850-856.
45. Li Z, Fan Y, Liu J, Li Y, Huan C, et al. (2012) Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 32: 1577-1584.
46. Geelen MJ, van Hoorn D, Beynen AC, (1999) Consumption of casein instead of soybean protein produces a transient rise in the concentration of sphingomyelin in VLDL in rats. J Nutr 129: 2119-2122.
47. Bladergroen BA, Beynen AC, Geelen MJ, (1999) Dietary pectin lowers sphingomyelin concentration in VLDL and raises hepatic sphingomyelinase activity in rats. J Nutr 129: 628-633.
48. Geelen MJ, Tijburg LB, Bouma CJ, Beynen AC, (1995) Cholesterol consumption alters hepatic sphingomyelin metabolism in rats. J Nutr 125: 2294-2300.
49. Geelen MJ, Beynen AC, (2000) Consumption of olive oil has opposite effects on plasma total cholesterol and sphingomyelin concentrations in rats. Br J Nutr 83: 541-547.
50. Ottestad I, Hassani S, Borge GI, Kohler A, Vogt G, et al. (2012) Fish Oil Supplementation Alters the Plasma Lipidomic Profile and Increases Long-Chain PUFAs of Phospholipids and Triglycerides in Healthy Subjects. PLoS One 7: e42550.
51. Bagdade JD, Buchanan WE, Levy RA, Subbaiah PV, Ritter MC, (1990) Effects of omega-3 fish oils on plasma lipids, lipoprotein composition, and postheparin lipoprotein lipase in women with IDDM. Diabetes 39: 426-431.
52. Nilsson A, Duan RD, (2006) Absorption and lipoprotein transport of sphingomyelin. J Lipid Res 47: 154-171.
53. Subbaiah PV, Liu M, (1993) Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins. Inhibition of lecithin-cholesterol acyltransferase reaction. J Biol Chem 268: 20156-20163.
54. Fournier N, Paul JL, Atger V, Cogny A, Soni T, et al. (1997) HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 17: 2685-2691.
55. Nuno-Ayala M, Guillen N, Navarro MA, Lou-Bonafonte JM, Arnal C, et al. (2010) Cysteinemia, rather than homocysteinemia, is associated with plasma apolipoprotein A-I levels in hyperhomocysteinemia: lipid metabolism in cystathionine beta-synthase deficiency. Atherosclerosis 212: 268-273.
56. Terpstra AH, Woodward CJ, Sanchez-Muniz FJ, (1981) Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualization by prestaining and rapid separation of serum lipoproteins from small volumes of serum. Anal Biochem 111: 149-157.
57. Kelley JL, Kruski AW, (1986) Density gradient ultracentrifugation of serum lipoproteins in a swinging Bucket rotor. Methods in Enzymology 128: 170-181.
58. Chapman MJ, (1986) Comparative analysis of mammalian plasma lipoproteins. Methods in Enzymology 128: 70-143.
59. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
60. Merril CR, Goldman D, Van Keuren ML, (1984) Gel protein stains: silver stains. Methods in Enzymology 104: 441-447.
61. Calleja L, Paris MA, Paul A, Vilella E, Joven J, et al. (1999) Low-cholesterol and high-fat diets reduce atherosclerotic lesion development in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 19: 2368-2375.
62. Navarro MA, Carpintero R, Acin S, Arbones-Mainar JM, Calleja L, et al. (2005) Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation. Cytokine 31: 52-63.
63. Hojjati MR, Jiang XC, (2006) Rapid, specific, and sensitive measurements of plasma sphingomyelin and phosphatidylcholine. J Lipid Res 47: 673-676.
64. He X, Chen F, McGovern MM, Schuchman EH, (2002) A fluorescence-based, high-throughput sphingomyelin assay for the analysis of Niemann-Pick disease and other disorders of sphingomyelin metabolism. Anal Biochem 306: 115-123.
65. Guillen N, Acin S, Navarro MA, Perona JS, Arbones-Mainar JM, et al. (2008) Squalene in a sex-dependent manner modulates atherosclerotic lesion which correlates with hepatic fat content in apoE-knockout male mice. Atherosclerosis 196: 558-564.
66. Arbonés-Mainar JM, Navarro MA, Acín S, Guzmán MA, Arnal C, et al. (2006) trans-10, cis-12- and cis-9, trans-11-Conjugated Linoleic Acid Isomers Selectively Modify HDL-Apolipoprotein Composition in Apolipoprotein E Knockout Mice. J Nutr 136: 353-359.
67. Bustin SA (2010) Why the need for qPCR publication guidelines?-The case for MIQE. Methods. 2009/12/23 ed. pp. 217-226.